ShawnGauravKwatraMD

Physician

Dr. Kwatra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
601 N Caroline St Ste 8065
Baltimore, MD 21287
Phone+1 410-955-5933

Fax+1 410-502-2309

Johns Hopkins UniversityResidency, Dermatology, 2012 - 2015
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2012

PubMed

A retrospective cohort study of the time between prior antibiotics and checkpoint inhibitors and association with survival in melanoma patients.
Jesse P Hirner, Ahmad Rajeh, Yevgeniy R Semenov, Shawn G Kwatra, Nicole R LeBoeuf
Journal of the American Academy of Dermatology. 2025-04-01
Association of sleep disturbance and itch intensity with quality-of-life impairment and disease severity in prurigo nodularis.
Weiying Lu, Selina M Yossef, Emily Z Ma, Jaya Manjunath, Yagiz M Akiska
The British Journal of Dermatology. 2025-03-18
Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis.
Daniela Frankel, Emily Ma, Davies Gage, Yagiz Matthew Akiska, Shahin Shahsavari
Journal of the American Academy of Dermatology. 2025-03-13

Topical Ruxolitinib Improves Itch, Blistering in Prurigo Nodularis in StudyMarch 17th, 2025
Topical JAK Inhibitor Active in Itchy Prurigo NodularisMarch 11th, 2025
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual MeetingMarch 8th, 2025
Join now to see all